WordNet

PrepTutorEJDIC

〈C〉〈U〉『偶然』,偶然のでき事;運,めぐり合わせ / 〈U〉〈C〉(何かが起こる)『公算』,見込み,可能性(probability) / 〈C〉『好機』,機会(opportunity) / 〈C〉危険,冒険;かけ / 《『chance to』 do》〈人が〉偶然;する / 《『it chances』+『that』『節』》〈物事が〉偶然に起こる / …'を'運を天に任せてする / 偶然の,はずみの

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

Spontaneous remission of proteinuria is a frequent event in phospholipase A2 receptor antibody-negative patients with membranous nephropathy.

Hoxha E1, Harendza S1, Pinnschmidt HO2, Tomas NM1, Helmchen U3, Panzer U1, Stahl RA1.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.Nephrol Dial Transplant.2015 Nov;30(11):1862-9. doi: 10.1093/ndt/gfv228. Epub 2015 Jul 3.
BACKGROUND: Phospholipase A2 receptor antibodies (PLA2R-Ab) and thrombospondin type-1 domain-containing 7A antibodies (THSD7A-Ab) are present in 70-80% of patients with membranous nephropathy (MN). Little, however, is known about the pathogenesis of MN and the clinical outcome in PLA2R-Ab- and THSD7
PMID 26142398

RECORD-2: phase II randomized study of everolimus and bevacizumab versus interferon α-2a and bevacizumab as first-line therapy in patients with metastatic renal cell carcinoma.

Ravaud A1, Barrios CH2, Alekseev B3, Tay MH4, Agarwala SS5, Yalcin S6, Lin CC7, Roman L8, Shkolnik M9, Anak O10, Gogov S10, Pelov D11, Louveau AL12, Melichar B13.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO.Ann Oncol.2015 Jul;26(7):1378-84. doi: 10.1093/annonc/mdv170. Epub 2015 Apr 7.
BACKGROUND: The open-label, phase II RECORD-2 trial compared efficacy and safety of first-line everolimus plus bevacizumab (EVE/BEV) with interferon plus bevacizumab (IFN/BEV) in patients with metastatic renal cell carcinoma.PATIENTS AND METHODS: Previously untreated patients were randomized 1:1 to
PMID 25851632

Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population.

Wu VC1, Huang KH2, Peng KY1, Tsai YC3, Wu CH4, Wang SM2, Yang SY1, Lin LY1, Chang CC5, Lin YH1, Lin SL1, Chu TS1, Wu KD1.
Scientific reports.Sci Rep.2015 Jun 12;5:11396. doi: 10.1038/srep11396.
Primary aldosteronism (PA) is a common form of secondary hypertension and has significant cardiovascular consequences. Mutated channelopathy due to the activation of calcium channels has been recently described in aldosterone-producing adenoma (APA). The study involved 148 consecutive PA patients, (
PMID 26066391

前川講平,柴野貴之,澤木潤子,高橋千晶,前寛,服部益治,谷澤隆邦
日本小児腎臓病学会雑誌 = Japanese journal of pediatric nephrology 22(1), 6-12, 2009-04-15
　膜性腎症は特発性と二次性に分類されるが，小児においては原因不明な特発性が多いといわれている。われわれは特発性膜性腎症 (IMN) と二次性のうち最も症例数の多かったHBV関連膜性腎症 (HBMN) を抽出し，後方視的に比較検討を行った。1985年から2007年までに当科で経験した膜性腎症のうち27例 (男児20例，女児7例) を対象とした。検討した膜性腎症27例のうち，特発性膜性腎症は17例とH …
NAID 10025170633

小谷卓矢,武内徹,阪本倫代,川崎善子,平野すずえ,田伏洋子,鍵谷真希,槇野茂樹,寺崎文生,花房俊昭
日本臨床免疫学会会誌 = Japanese journal of clinical immunology 28(6), 413-417, 2005-12-31
患者は37歳女性．1991年に腎炎を伴う全身性エリテマトーデス（SLE）と診断された．prednisolone（以下PSL），cyclophosphamide，mizoribineの併用にて加療され，蛋白尿が持続したが病勢は安定していた．2002年6月より労作時胸痛が出現し入院となった．胸骨左縁第2肋間に収縮期雑音を聴取した．検査所見では蛋白尿と貧血を認めたが，抗ds-DN …
NAID 10020414945